Gd1b-derived gangliosides modulate fcεri endocytosis in mast cells

Journal of Histochemistry and Cytochemistry

Volumn 59, Issue 4, 2011, Pages 428-440

  Mazucato, Vivian Marino ^a   Silveira e Souza, Adriana Maria Mariano ^a   Nicoletti, Liliana Martos ^a   Jamur, Maria Célia ^a   Oliver, Constance ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Electron microscopy; Endocytosis; Fluorescence microscopy; Gangliosides; High affinity ige receptor; Mast cells

Indexed keywords

FC RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; GANGLIOSIDE GD 1B; HIGH AFFINITY IGE RECEPTOR; IMMUNOGLOBULIN E RECEPTOR; UNCLASSIFIED DRUG; FCEPSILONRI PROTEIN, RAT; GANGLIOSIDE; GANGLIOSIDE, GD1B;

ALPHA CHAIN; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL FUSION; CELL MEMBRANE; CELL SIZE; CELL STRAIN; CELL STRAIN D1; CELL STRAIN E5; COCULTURE; CONTROLLED STUDY; CYTOPLASM; DISPERSION; ENDOCYTOSIS; ENDOSOME; IMMUNOMODULATION; INTERNALIZATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL LINE; GENETICS; MUTATION; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; CELL LINE; ENDOCYTOSIS; GANGLIOSIDES; MAST CELLS; MUTATION; PROTEIN TRANSPORT; RATS; RECEPTORS, IGE;

EID: 79955685135     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155411400868     Document Type: Article

References (81)

1. Allende ML, Proia RL. 2002. Lubricating cell signaling pathways with gangliosides. Curr Opin Struct Biol. 12:587-592.
2. Barsumian EL, Isersky C, Petrino MG, Siraganian RP. 1981. IgEinduced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur J Immunol. 11:317-323.
3. Basciano LK, Berenstein EH, Kmak L, Siraganian RP. 1986. Monoclonal antibodies that inhibit IgE binding. J Biol Chem. 261:11823-11831.
4. Birkle S, Zeng G, Gao L, Yu RK, Aubry J. 2003. Role of tumorassociated gangliosides in cancer progression. Biochimie. 85:455-463.
5. Boehm M, Bonifacino JS. 2001. Adaptins: the final recount. Mol Biol Cell. 12:2907-2920.
6. Bonifacino JS, Hurley JH. 2008. Retromer. Curr Opin Cell Biol. 20:427-436.
7. Bonifacino JS, Traub LM. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem. 72:395-447.
8. Bremer EG, Hakomori S, Bowen-Pope DF, Raines E, Ross R. 1984. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem. 259:6818-6825.
9. Brown DA, London E. 1998. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol. 14:111-136.
10. Carlton J, Bujny M, Peter BJ, Oorschot VM, Rutherford A, Mellor H, Klumperman J, McMahon HT, Cullen PJ. 2004. Sorting nexin-1 mediates tubular endosome-to-TGN transport through coincidence sensing of high-curvature membranes and 3-phosphoinositides. Curr Biol. 14:1791-1800.
11. Carlton JG, Bujny MV, Peter BJ, Oorschot VM, Rutherford A, Arkell RS, Klumperman J, McMahon HT, Cullen PJ. 2005. Sorting nexin-2 is associated with tubular elements of the early endosome, but is not essential for retromer-mediated endosome-to-TGN transport. J Cell Sci. 118:4527-4539.
12. Ceresa BP, Schmid SL. 2000. Regulation of signal transduction by endocytosis. Curr Opin Cell Biol. 12:204-210.
13. Cheresh DA, Pytela R, Pierschbacher MD, Klier FG, Ruoslahti E, Reisfeld RA. 1987. An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cationdependent functional complex with the disialoganglioside GD2. J Cell Biol. 105:1163-1173.
14. Crain SM, Shen KF. 1998. GM1 ganglioside-induced modulation of opioid receptor-mediated functions. Ann N Y Acad Sci. 845:106-125.
15. Crain SM, Shen KF. 2004. Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptormediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice. Brain Res. 995:260-266.
16. Dautry-Varsat A, Ciechanover A, Lodish HF. 1983. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci U S A. 80:2258-2262.
17. Delprato A, Merithew E, Lambright DG. 2004. Structure, exchange determinants, and family-wide rab specificity of the tandem helical bundle and Vps9 domains of Rabex-5. Cell. 118:607-617.
18. Deng W, Li R, Ladisch S. 2000. Influence of cellular ganglioside depletion on tumor formation. J Natl Cancer Inst. 92:912-917.
19. Dunn KW, McGraw TE, Maxfield FR. 1989. Iterative fractionation of recycling receptors from lysosomally destined ligands in an early sorting endosome. J Cell Biol. 109:3303-3314.
20. Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ. 1998. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem. 273:20121-20127.
21. Field KA, Apgar JR, Hong-Geller E, Siraganian RP, Baird B, Holowka D. 2000. Mutant RBL mast cells defective in Fc epsilon RI signaling and lipid raft biosynthesis are reconstituted by activated Rho-family GTPases. Mol Biol Cell. 11:3661-3673.
22. Fishman PH. 1986. Recent advances in identifying the functions of gangliosides. Chem Phys Lipids. 42:137-151.
23. Flores-Diaz M, Alape-Giron A, Clark G, Catimel B, Hirabayashi Y, Nice E, Gutierrez JM, Titball R, Thelestam M. 2005. A cellular deficiency of gangliosides causes hypersensitivity to Clostridium perfringens phospholipase C. J Biol Chem. 280:26680-26689.
24. Ganley IG, Carroll K, Bittova L, Pfeffer S. 2004. Rab9 GTPase regulates late endosome size and requires effector interaction for its stability. Mol Biol Cell. 15:5420-5430.
25. Gruenberg J, Stenmark H. 2004. The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol. 5:317-323.
26. Guo NH, Her GR, Reinhold VN, Brennan MJ, Siraganian RP, Ginsburg V. 1989. Monoclonal antibody AA4, which inhibits binding of IgE to high affinity receptors on rat basophilic leukemia cells, binds to novel alpha-galactosyl derivatives of ganglioside GD1b. J Biol Chem. 264:13267-13272.
27. Haft CR, de la Luz Sierra M, Barr VA, Haft DH, Taylor SI. 1998. Identification of a family of sorting nexin molecules and characterization of their association with receptors. Mol Cell Biol. 18:7278-7287.
28. Hakomori S. 1990. Bifunctional role of glycosphingolipids: modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem. 265:18713-18716.
29. Hakomori S. 1993. Structure and function of sphingoglycolipids in transmembrane signalling and cell-cell interactions. Biochem Soc Trans. 21(Pt 3):583-595.
30. Hakomori S. 1996a. Sphingolipid-dependent protein kinases. Adv Pharmacol. 36:155-171.
31. Hakomori S. 1996b. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56:5309-5318.
32. Hannun YA, Bell RM. 1989. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science. 243:500-507.
33. Herbst JJ, Opresko LK, Walsh BJ, Lauffenburger DA, Wiley HS. 1994. Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention. J Biol Chem. 269:12865-12873.
34. Holowka D, Baird B. 2001. Fc(epsilon)RI as a paradigm for a lipid raft-dependent receptor in hematopoietic cells. Semin Immunol. 13:99-105.
35. Holowka D, Sheets ED, Baird B. 2000. Interactions between Fc(epsilon)RI and lipid raft components are regulated by the actin cytoskeleton. J Cell Sci. 113(Pt 6):1009-1019.
36. Hong-Geller E, Holowka D, Siraganian RP, Baird B, Cerione RA. 2000. Cdc42 and Rac stimulate exocytosis of secretory granules by activating the IP(3)/calcium pathway in RBL-2H3 mast cells. J Cell Biol. 148:481-494.
37. Igarashi Y, Nojiri H, Hanai N, Hakomori S. 1989. Gangliosides that modulate membrane protein function. Methods Enzymol. 179:521-541.
38. Kabayama K, Sato T, Saito K, Loberto N, Prinetti A, Sonnino S, Kinjo M, Igarashi Y, Inokuchi J. 2007. Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci U S A. 104:13678-13683.
39. Kuronita T, Eskelinen EL, Fujita H, Saftig P, Himeno M, Tanaka Y. 2002. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J Cell Sci. 115:4117-4131.
40. Livingston PO, Shiku H, Bean MA, Pinsky CM, Oettgen HF, Old LJ. 1979. Cell-mediated cytotoxicity for cultured autologous melanoma cells. Int J Cancer. 24:34-44.
41. Lombardi D, Soldati T, Riederer MA, Goda Y, Zerial M, Pfeffer SR. 1993. Rab9 functions in transport between late endosomes and the trans Golgi network. Embo J. 12:677-682.
42. Lopez PH, Schnaar RL. 2009. Gangliosides in cell recognition and membrane protein regulation. Curr Opin Struct Biol. 19:549-557.
43. Marsh M, McMahon HT. 1999. The structural era of endocytosis. Science. 285:215-220.
44. Martini F, Riondino S, Pignatelli P, Gazzaniga PP, Ferroni P, Lenti L. 2002. Involvement of GD3 in platelet activation: a novel association with Fcgamma receptor. Biochim Biophys Acta. 1583:297-304.
45. Mayor S, Presley JF, Maxfield FR. 1993. Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk flow process. J Cell Biol. 121:1257-1269.
46. Mellman I. 1996. Endocytosis and molecular sorting. Annu Rev Cell Dev Biol. 12:575-625.
47. Miljan EA, Meuillet EJ, Mania-Farnell B, George D, Yamamoto H, Simon HG, Bremer EG. 2002. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J Biol Chem. 277:10108-10113.
48. Mullin BR, Fishman PH, Lee G, Aloj SM, Ledley FD, Winand RJ, Kohn LD, Brady RO. 1976. Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors. Proc Natl Acad Sci U S A. 73:842-846.
49. Oliver C, Fujimura A, Silveira ESAM, Orlandini de Castro R, Siraganian RP, Jamur MC. 2007. Mast cell-specific gangliosides and FcepsilonRI follow the same endocytic pathway from lipid rafts in RBL-2H3 cells. J Histochem Cytochem. 55:315-325.
50. Oliver C, Sahara N, Kitani S, Robbins AR, Mertz LM, Siraganian RP. 1992. Binding of monoclonal antibody AA4 to gangliosides on rat basophilic leukemia cells produces changes similar to those seen with Fc epsilon receptor activation. J Cell Biol. 116:635-646.
51. Pearse BM. 1975. Coated vesicles from pig brain: purification and biochemical characterization. J Mol Biol. 97:93-98.
52. Pfeffer SR. 2009. Multiple routes of protein transport from endosomes to the trans Golgi network. FEBS Lett. 583:3811-3816.
53. Pfeiffer JR, Seagrave JC, Davis BH, Deanin GG, Oliver JM. 1985. Membrane and cytoskeletal changes associated with IgEmediated serotonin release from rat basophilic leukemia cells. J Cell Biol. 101:2145-2155.
54. Pike LJ, Han X, Chung KN, Gross RW. 2002. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry. 41:2075-2088.
55. Rebbaa A, Hurh J, Yamamoto H, Kersey DS, Bremer EG. 1996. Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology. 6:399-406.
56. Reynolds ES. 1963. The use of lead citrate at high pH as an electronopaque stain in electron microscopy. J Cell Biol. 17:208-212.
57. Riederer MA, Soldati T, Shapiro AD, Lin J, Pfeffer SR. 1994. Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi network. J Cell Biol. 125:573-582.
58. Rios EJ, Piliponsky AM, Ra C, Kalesnikoff J, Galli SJ. 2008. Rabaptin-5 regulates receptor expression and functional activation in mast cells. Blood. 112:4148-4157.
59. Rivera J, Arudchandran R, Gonzalez-Espinosa C, Manetz TS, Xirasagar S. 2001. A perspective: regulation of IgE receptormediated mast cell responses by a LAT-organized plasma membrane-localized signaling complex. Int Arch Allergy Immunol. 124:137-141.
60. Rojas R, van Vlijmen T, Mardones GA, Prabhu Y, Rojas AL, Mohammed S, Heck AJ, Raposo G, van der Sluijs P, Bonifacino JS. 2008. Regulation of retromer recruitment to endosomes by sequential action of Rab5 and Rab7. J Cell Biol. 183:513-526.
61. Schmidt H, Gelhaus C, Lucius R, Nebendahl M, Leippe M, Janssen O. 2009. Enrichment and analysis of secretory lysosomes from lymphocyte populations. BMC Immunol. 10:41.
62. Seagrave J, Pfeiffer JR, Wofsy C, Oliver JM. 1991. Relationship of IgE receptor topography to secretion in RBL-2H3 mast cells. J Cell Physiol. 148:139-151.
63. Sheets ED, Holowka D, Baird B. 1999. Membrane organization in immunoglobulin E receptor signaling. Curr Opin Chem Biol. 3:95-99.
64. Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL. 1999. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A. 96:7532-7537.
65. Silveira e Souza AM, Mazucato VM, de Castro RO, Matioli F, Ciancaglini P, de Paiva Paulino T, Jamur MC, Oliver C. 2008. The alpha-galactosyl derivatives of ganglioside GD(1b) are essential for the organization of lipid rafts in RBL-2H3 mast cells. Exp Cell Res. 314:2515-2528.
66. Silveira e Souza AM, Trindade ES, Jamur MC, Oliver C. 2010. Gangliosides are important for the preservation of the structure and organization of RBL-2H3 mast cells. J Histochem Cytochem. 58:83-93.
67. Simonsen A, Lippe R, Christoforidis S, Gaullier JM, Brech A, Callaghan J, Toh BH, Murphy C, Zerial M, Stenmark H. 1998. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature. 394:494-498.
68. Stephan V, Seibt A, Dukanovic D, Skasa M, Swaim WD, Berenstein EH, Siraganian RP, Wahn V. 1997. Anti-ganglioside monoclonal antibody AA4 selectively inhibits IgE-induced signal transduction pathways in rat basophilic leukemia cells. Mol Immunol. 34:227-235.
69. Stump RF, Pfeiffer JR, Schneebeck MC, Seagrave JC, Oliver JM. 1989. Mapping gold-labeled receptors on cell surfaces by backscattered electron imaging and digital image analysis: studies of the IgE receptor on mast cells. Am J Anat. 185:128-141.
70. Sugiura Y, Furukawa K, Tajima O, Mii S, Honda T, Furukawa K. 2005. Sensory nerve-dominant nerve degeneration and remodeling in the mutant mice lacking complex gangliosides. Neuroscience. 135:1167-1178.
71. Swaim WD, Minoguchi K, Oliver C, Hamawy MM, Kihara H, Stephan V, Berenstein EH, Siraganian RP. 1994. The antiganglioside monoclonal antibody AA4 induces protein tyrosine phosphorylations, but not degranulation, in rat basophilic leukemia cells. J Biol Chem. 269:19466-19473.
72. Tagami S, Inokuchi J.J, Kabayama K, Yoshimura H, Kitamura F, Uemura S, Ogawa C, Ishii A, Saito M, Ohtsuka Y, et al. 2002. Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem. 277:3085-3092.
73. Van Der Sluijs P, Hull M, Zahraoui A, Tavitian A, Goud B, Mellman I. 1991. The small GTP-binding protein rab4 is associated with early endosomes. Proc Natl Acad Sci U S A. 88:6313-6317.
74. van Meel E, Klumperman J. 2008. Imaging and imagination: understanding the endo-lysosomal system. Histochem Cell Biol. 129:253-266.
75. Wang J, Lu ZH, Gabius HJ, Rohowsky-Kochan C, Ledeen RW, Wu G. 2009. Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J Immunol. 182:4036-045.
76. Wang XQ, Sun P, Paller AS. 2002. Ganglioside modulation regulates epithelial cell adhesion and spreading via gangliosidespecific effects on signaling. J Biol Chem. 277:40410-40419.
77. Wilson BS, Pfeiffer JR, Oliver JM. 2000. Observing FcepsilonRI signaling from the inside of the mast cell membrane. J Cell Biol. 149:1131-1142.
78. Wu G, Lu ZH, Alfinito P, Ledeen RW. 1997. Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: competitive interactions. Neurochem Res. 22:1281-1289.
79. Wu G, Lu ZH, Ledeen RW. 1997. Interaction of the delta-opioid receptor with GM1 ganglioside: conversion from inhibitory to excitatory mode. Brain Res Mol Brain Res. 44:341-346.
80. Yamashita T, Wada R, Sasaki T, Deng C, Bierfreund U, Sandhoff K, Proia RL. 1999. A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci U S A. 96:9142-9147.
81. Zhang M, Chen L, Wang S, Wang T. 2009. Rab7: roles in membrane trafficking and disease. Biosci Rep. 29:193-209.